Navigation Links
Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011
Date:10/25/2011

ST. LOUIS, Oct. 25, 2011 /PRNewswire/ --Stereotaxis, Inc. (NASDAQ: STXS) today announced that it will release financial results for the third quarter ended September 30, 2011 on Monday, November 7, 2011 after the close of the U.S. financial markets.  The Company will host a conference call and webcast on Monday, November 7, 2011 at 4:30 p.m. Eastern Time to discuss the Company's third quarter results and corporate developments.Conference call details:Date:

Monday, November 7, 2011Time:

4:30 p.m. ETDial-in (U.S.):

800-762-8779Dial-in (International):

480-629-9771Web cast:

www.stereotaxis.comTo access an audio replay of the call:Replay (U.S.):

800-406-7325Replay (International):

303-590-3030Replay Passcode:

4484029About Stereotaxis
www.stereotaxis.com
www.odysseyexperience.comStereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation and reduced x-ray exposure.

Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and aroun
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Stereotaxis Announces Public Offering of Common Stock
4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Installs First System in Taiwan
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ATLANTA , July 6, 2015 Celtaxsys, ... anti-inflammatory therapeutics, including those with rare and orphan inflammatory ... from the U.S. Food and Drug Administration (FDA) to ... drug candidate, acebilustat (CTX-4430), in adult CF patients in ... in Europe will be filed ...
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
(Date:7/5/2015)... , July 6, 2015 Nihon ... international symposium on Medical-Engineering Collaboration "Medicine Definitely ... July 10, 2015 in Tokyo, Japan ... its medical applied research will present their achievements ... and a new industry produced with 8K technology. ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
... /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ... worldwide, today announced that it will report its financial results ... U.S. market closes on May 9, 2011. Mindray,s management will ... 10, 2011 U.S. Eastern Time (8:00 PM on May 10, ...
... Corporation (OTCBB: PRTT) today announced its Board of Directors ... its Chief Executive Officer and Chairman of the Board, ... Operating Officer and Board Member in March 2011, following ... was the Founder and CEO. Mr. Sesha ...
Cached Medicine Technology:Mindray to Report First Quarter 2011 Financial Results on May 9, 2011 2Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2
(Date:7/6/2015)... ... July 06, 2015 , ... ... that Randstad Technologies selected Aspect Software Unified IP contact center solution hosted by ... selected Aspect Unified IP as its future call center platform. , Promero ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Diabetes affects many ... More than 29 million Americans have diabetes, the majority of which are Type 2. ... adults or more than one in three, have prediabetes (abnormally high blood sugar levels). ...
(Date:7/6/2015)... Harlingen, Texas (PRWEB) , ... July 06, 2015 , ... ... a thought-provoking look into the economic transformation associated with the U.S. economy over the ... macroeconomic consequences associated with its use. In many ways, the book is a time ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... City Sports, ... City Sports will co-produce two training clinics for first-time triathletes this summer with ethos, ... will take place on Thursday, July 9, at 6:00 p.m. at the North End ...
(Date:7/5/2015)... (PRWEB) , ... July 05, 2015 , ... ... patented products, announces the Weed Master, a landscaping invention that effectively removes ... $75 billion US dollars," says Scott Cooper, CEO and Creative Director of World ...
Breaking Medicine News(10 mins):Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5
... clues to the impact of severe physical, psychosocial suffering, ... Among Jewish survivors of World War II, those who ... risk of cancer, likely due to physical and mental ... Haifa researchers compared cancer rates in more than 300,000 ...
... women, wide waists in men spell trouble, study finds , ... body fat appears to affect the risk of dangerous blood ... women, a new Danish study indicates. , The 10-year study ... of venous thromboembolism (VTE) in women but not men, while ...
... habits can stave off the inevitable declines, research finds , ... that accompany growing old typically speed up after the age ... can slow the inevitable by staying lean, exercising and refraining ... issue of the Archives of Internal Medicine , are ...
... say , MONDAY, Oct. 26 (HealthDay News) -- There,s ... the family safe on Halloween. Some simple precautions will ... , The American Academy of Pediatrics offers the following ... and reflective and short enough to prevent tripping, entanglement ...
... shows they have doubled risk of GERD, may be linked ... World Trade Center rescue workers can add another illness to ... exposure to Ground Zero toxins and the ensuing mental anguish ... A new study shows that 41 percent of World Trade ...
... Oct. 26 Uno Chicago Grill®, America,s Healthiest Chain Restaurant(1), ... fall menu. , This exciting fall menu stars ... are a well-known and popular accent to many dishes, UNO ... the territory of a select few health food aficionados. ...
Cached Medicine News:Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Where You Put on Pounds May Influence Clot Risk 2Health News:Fitness Fades Fast After 45 2Health News:Fitness Fades Fast After 45 3Health News:Treat Kids to a Safe Halloween 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 3Health News:Go, Go, Goji! UNO(R) Fall Menu Is 'Berry' Delicious 2Health News:Go, Go, Goji! UNO(R) Fall Menu Is 'Berry' Delicious 3
... the Finntip Wide is designed especially for ... genomic DNA. This tip eliminates the mechanical ... excellent for use with extremely viscous liquids. ... of the orifice is 1.1 mm or ...
... Finntips have been designed to optimize ... quality of our tip products is widely ... Finntip range has been extended over the ... of standard and special tips including filter ...
... Premium Low Binding, Graduated, Long Reach Pipet Tips ... and 10 L. Reduces DNA and protein binding. ... of Ultra-Micro Pipettors up to 10 L. Produced ... free. AVR9LS is the Sterile Racked packaged 96 ...
... disposable pipette tips, TowerPacks are ... Each Sterilized TowerPack is individually ... to help protect tips from ... the red sticker, which indicates ...
Medicine Products: